The Journal of Neuroscience, January 7, 2004, 24(1):1-7; doi:10.1523/JNEUROSCI.3792-03.2004
Previous Article | Next Article 
Cellular/Molecular
Production and Release of Neuroprotective Tumor Necrosis Factor by P2X7 Receptor-Activated Microglia
Tomohisa Suzuki,1
Izumi Hide,1
Katsutoshi Ido,1
Shinichi Kohsaka,2
Kazuhide Inoue,3,4 and
Yoshihiro Nakata1
1Department of Pharmacology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima 734-8551, Japan, 2Department of Neurochemistry, National Institute of Neuroscience, Tokyo 187-8502, Japan, 3Division of Biosignaling, National Institute of Health Science, Tokyo 158-8501, Japan, and 4Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan
After a brain insult, ATP is released from injured cells and activates microglia. The microglia that are activated in this way then release a range of bioactive substances, one of which is tumor necrosis factor (TNF). The release of TNF appears to be dependent on the P2X7 receptor. The inhibitors 1,4-diamino-2,3-dicyano-1,4-bis[2-amino-phenylthio]butadiene (U0126), anthra[1,9-cd]pyrazol-6(2H)-one (SP600125), and 4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)IH-imidazole (SB203580), which target MEK (mitogen-activated protein kinase kinase), JNK (c-Jun N-terminal kinase), and p38, respectively, all potently suppress the production of TNF in ATP-stimulated microglia, whereas the production of TNF mRNA is strongly inhibited by U0126 and SP600125. SB203580 did not affect the increased levels of TNF mRNA but did prevent TNF mRNA from accumulating in the cytoplasm. The ATP-provoked activation of JNK and p38 [but not extracellular signal-regulated kinase (ERK)] could be inhibited by brilliant blue G, a P2X7 receptor blocker, and by genistein and 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-D]pyrimidine, which are general and src-family-specific tyrosine kinase inhibitors, respectively. Most important, we found that treatment of the microglia in neuron-microglia cocultures with the P2X7 agonist 2'-3'-O-(benzoyl-benzoyl) ATP led to significant reductions in glutamate-induced neuronal cell death, and that either TNF-
converting enzyme inhibitor or anti-TNF readily suppressed the protective effect implied by this result. Together, these findings indicate that both ERK and JNK are involved in the regulation of TNF mRNA expression, that p38 is involved in the nucleocytoplasmic transport of TNF mRNA, and that a PTK (protein tyrosine kinase), possibly a member of the src family, acts downstream of the P2X7 receptor to activate JNK and p38. Finally, our data suggest that P2X7 receptor-activated microglia protect neurons against glutamate toxicity primarily because they are able to release TNF.
Key words: P2X7 receptor; TNF; MAP kinase; ATP; microglia; neuroprotection
Received Aug 14, 2003;
revised October 6, 2003;
accepted October 7, 2003.
This article has been cited by other articles:
|
|
|
|
 
R. Rizzo, D. Ferrari, L. Melchiorri, M. Stignani, S. Gulinelli, O. R. Baricordi, and F. Di Virgilio
Extracellular ATP Acting at the P2X7 Receptor Inhibits Secretion of Soluble HLA-G from Human Monocytes
J. Immunol.,
October 1, 2009;
183(7):
4302 - 4311.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Peng, M. L. Cotrina, X. Han, H. Yu, L. Bekar, L. Blum, T. Takano, G.-F. Tian, S. A. Goldman, and M. Nedergaard
From the Cover: Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury
PNAS,
July 28, 2009;
106(30):
12489 - 12493.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Gonzalo-Gobernado, D. Reimers, A. S. Herranz, J. J. Diaz-Gil, C. Osuna, M. J. Asensio, S. Baena, M. Rodriguez-Serrano, and E. Bazan
Mobilization of Neural Stem Cells and Generation of New Neurons in 6-OHDA-lesioned Rats by Intracerebroventricular Infusion of Liver Growth Factor
J. Histochem. Cytochem.,
May 1, 2009;
57(5):
491 - 502.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Monif, C. A. Reid, K. L. Powell, M. L. Smart, and D. A. Williams
The P2X7 Receptor Drives Microglial Activation and Proliferation: A Trophic Role for P2X7R Pore
J. Neurosci.,
March 25, 2009;
29(12):
3781 - 3791.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Noguchi, K. Ishii, H. Fukutomi, I. Naguro, A. Matsuzawa, K. Takeda, and H. Ichijo
Requirement of Reactive Oxygen Species-dependent Activation of ASK1-p38 MAPK Pathway for Extracellular ATP-induced Apoptosis in Macrophage
J. Biol. Chem.,
March 21, 2008;
283(12):
7657 - 7665.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. V. Gourine, N. Dale, E. Llaudet, D. M. Poputnikov, K. M. Spyer, and V. N. Gourine
Release of ATP in the central nervous system during systemic inflammation: real-time measurement in the hypothalamus of conscious rabbits
J. Physiol.,
November 15, 2007;
585(1):
305 - 316.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Koedel, U. M. Merbt, C. Schmidt, B. Angele, B. Popp, H. Wagner, H.-W. Pfister, and C. J. Kirschning
Acute Brain Injury Triggers MyD88-Dependent, TLR2/4-Independent Inflammatory Responses
Am. J. Pathol.,
July 1, 2007;
171(1):
200 - 213.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. B. Choi, J. K. Ryu, S. U. Kim, and J. G. McLarnon
Modulation of the Purinergic P2X7 Receptor Attenuates Lipopolysaccharide-Mediated Microglial Activation and Neuronal Damage in Inflamed Brain
J. Neurosci.,
May 2, 2007;
27(18):
4957 - 4968.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Burnstock
Physiology and Pathophysiology of Purinergic Neurotransmission
Physiol Rev,
April 1, 2007;
87(2):
659 - 797.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. J. Liu, A. Kalous, E. L. Werry, and M. R. Bennett
Purine Release from Spinal Cord Microglia after Elevation of Calcium by Glutamate
Mol. Pharmacol.,
September 1, 2006;
70(3):
851 - 859.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Reimers, A. S. Herranz, J. J. Diaz-Gil, M. V. T. Lobo, C. L. Paino, R. Alonso, M. J. Asensio, R. Gonzalo-Gobernado, and E. Bazan
Intrastriatal Infusion of Liver Growth Factor Stimulates Dopamine Terminal Sprouting and Partially Restores Motor Function in 6-Hydroxydopamine-lesioned Rats
J. Histochem. Cytochem.,
April 1, 2006;
54(4):
457 - 465.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Chen and C. F. Brosnan
Exacerbation of Experimental Autoimmune Encephalomyelitis in P2X7R-/- Mice: Evidence for Loss of Apoptotic Activity in Lymphocytes.
J. Immunol.,
March 1, 2006;
176(5):
3115 - 3126.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Auger, I. Motta, K. Benihoud, D. M. Ojcius, and J. M. Kanellopoulos
A Role for Mitogen-activated Protein KinaseErk1/2 Activation and Non-selective Pore Formation in P2X7 Receptor-mediated Thymocyte Death
J. Biol. Chem.,
July 29, 2005;
280(30):
28142 - 28151.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. M. Mitrasinovic, A. Grattan, C. C. Robinson, N. B. Lapustea, C. Poon, H. Ryan, C. Phong, and G. M. Murphy Jr
Microglia Overexpressing the Macrophage Colony-Stimulating Factor Receptor Are Neuroprotective in a Microglial-Hippocampal Organotypic Coculture System
J. Neurosci.,
April 27, 2005;
25(17):
4442 - 4451.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. X. Faria, F. P. DeFarias, and L. A. Alves
Are second messengers crucial for opening the pore associated with P2X7 receptor?
Am J Physiol Cell Physiol,
February 1, 2005;
288(2):
C260 - C271.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. E. Peterson, S. Hughes, D. E. Dimcheff, K. Wehrly, and B. Chesebro
Separate Sequences in a Murine Retroviral Envelope Protein Mediate Neuropathogenesis by Complementary Mechanisms with Differing Requirements for Tumor Necrosis Factor Alpha
J. Virol.,
December 1, 2004;
78(23):
13104 - 13112.
[Abstract]
[Full Text]
[PDF]
|
|
|
